Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "central"

837 News Found

$7 million grant to UW Institute for protein design to fuel next-gen enzyme breakthroughs
R&D | March 23, 2026

$7 million grant to UW Institute for protein design to fuel next-gen enzyme breakthroughs

The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington


Zydus launches Aerolife Mini to simplify inhaler use for asthma and COPD patients
News | March 20, 2026

Zydus launches Aerolife Mini to simplify inhaler use for asthma and COPD patients

India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease


LANXESS marks 40 yrs of animal disease defense 'Virkon S'
News | March 20, 2026

LANXESS marks 40 yrs of animal disease defense 'Virkon S'

A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone


Mankind Pharma acquires Rivotril brand for India
News | March 19, 2026

Mankind Pharma acquires Rivotril brand for India

Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions


PsiQuantum joins forces with Japan’s National Cancer Center to revolutionize cancer research with quantum computing
R&D | March 18, 2026

PsiQuantum joins forces with Japan’s National Cancer Center to revolutionize cancer research with quantum computing

The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications


Co-Diagnostics bags key Japanese patent, bolstering global push for rapid PCR testing
News | March 14, 2026

Co-Diagnostics bags key Japanese patent, bolstering global push for rapid PCR testing

The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process


Shilpa Biologicals and mAbTree Biologics secure ODD from USFDA
Drug Approval | March 13, 2026

Shilpa Biologicals and mAbTree Biologics secure ODD from USFDA

Marks significant milestone for breakthrough biologic to treat rare blood cancers